Clinical Trial Update: A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating elagolix for moderate to severe endometriosis-associated pain completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Endometriosis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-18